The dental implants and prosthetics market was valued at US$8.714 billion in 2018 and is projected to expand at a CAGR of 7.96% over the forecast period to reach US$13.793 billion by 2024. The rise in demand for implants and prosthetics is majorly attributed to the growing demand for cosmetic dentistry. Dental implants and prosthetics are used for either filling oral cavities or replacing them with a concrete solution. According to WHO, more than 3 billion people in the world are affected by Read more...
Smart Healthcare Devices market is projected to grow at a CAGR of 16.14% during the forecast period, reaching a total market size of US$232.642 billion in 2024 from US$94.790 billion in 2018. Smart Healthcare means the use of electronics and other internet of things (IoT) for better diagnosis of diseases, improved treatment of patients, and enhanced quality of life. It helps in giving real-time health-related information of patients and thereby supporting chronic disease management and remote Read more...
Neurosurgical Robotics market is projected to grow at a CAGR of 14.22% during the forecast period, reaching a total market size of US$136.764 million in 2024 from US$61.596 million in 2018. Robotic neurosurgery offers high precision access to the complex and sensitive regions and thereby assisting in microsurgery and minimally invasive surgery. Increasing number of neurosurgeries performed globally and rising geriatric population are boosting the growth of neurosurgical robotics market. Increa Read more...
The Argentina MRI market is projected to grow at a CAGR of 2.63% to reach US$0.109 billion by 2024, from US$0.093 billion in 2018. The MRI market in Argentina is growing owing to the prevalence of the elderly population, and the prevalence of chronic diseases. Furthermore, growing health expenditure is augmenting the market growth during the forecast period. In addition, growing research activities will provide an opportunity for MRI installations for research and clinical purposes during t Read more...
The Middle East and Africa drug delivery market is projected to grow at a CAGR of 11.90% to reach US$ 40.744 billion by 2024, from US$ 22.128 billion in 2018. The drug delivery market in Middle East and Africa is poised to grow at a fast pace owing to the growing geriatric population, and the prevalence of chronic diseases. Furthermore, improvement in health systems is augmenting the market growth during the forecast period. This research study examines the current market trends rela Read more...
The South America drug delivery market is projected to grow at a CAGR of 11.60% to reach US$ 57.300 billion by 2024, from US$ 29.654 billion in 2018. The drug delivery market in South America is poised to grow at a rapid pace owing to the growing pharmaceutical market, an aging population, and the prevalence of chronic diseases. Furthermore, growing health expenditure is augmenting the market growth during the forecast period. This research study examines the current market trends re Read more...
The Oral drug delivery market is projected to grow at a CAGR of 6.99% to reach US$ 150.003 billion by 2024. Oral drug delivery is referred to the transfer of drug into the human body through an oral route of administration. This is considered as the most convenient route of administration and is preferred widely among a wide range of consumers. These are in high demand due to the prevalence of chronic diseases worldwide. Furthermore, rising R&D investment, growing health expenditure and a Read more...
The nasal drug delivery market is projected to grow at a CAGR of 6.58% to reach US$76.083 billion by 2024, from US$51.917billion in 2018. Nasal drug delivery is referred to the transfer of drug into the human body through an intranasal route of administration. These are in high demand owing to the convenience of administration in addition to providing improved patient compliance. Also, there are certain drugs which are not suitable for oral or parenteral administration, thus, calling for the Read more...
The injectable drug delivery market is projected to grow at a CAGR of 10.37% to reach US$ 804.844 billion by 2024. Injectable drug delivery is considered to be the most effective means of drug delivery into the human body and is thus considered to be the most effective administration route. These are in high demand due to the prevalence of chronic diseases worldwide driving the market growth during the forecast period. Furthermore, growing R&D activities, growing health expenditure and gr Read more...
.jpg)
